Abdominal pain, a common complaint in clinical practice, presents a diagnostic challenge due to its diverse etiology. It requires a comprehensive approach for effective evaluation and management.
The first step involves a thorough history and physical examination. The location, character, duration, and associated symptoms of the pain can provide valuable clues to its origin. It's crucial to consider 'red flag' symptoms such as weight loss, anemia, and gastrointestinal bleeding, which may indicate serious underlying pathology.
Basic laboratory tests, including a complete blood count, liver function tests, and serum electrolytes, are generally recommended. Depending on the clinical suspicion, more specific tests like amylase, lipase, or tumor markers may be warranted.
Imaging plays a pivotal role in the evaluation of abdominal pain. Ultrasound is often the first-line modality, especially for gallbladder and gynecological pathology. Computed tomography (CT) provides a more comprehensive view of the abdomen and pelvis and is particularly useful in acute settings. Magnetic resonance imaging (MRI) can be reserved for specific indications.
Endoscopy allows direct visualization of the gastrointestinal tract and is indispensable in diagnosing conditions like peptic ulcer disease, gastritis, and malignancies. Both upper and lower endoscopy should be considered based on the patient's symptoms and risk factors.
If initial investigations fail to reveal a diagnosis, referral to a specialist such as a gastroenterologist, surgeon, or gynecologist may be necessary. Multidisciplinary collaboration is often key to managing complex cases.
Abdominal pain is a multifaceted problem that necessitates a systematic approach for effective management. By integrating a thorough history, targeted investigations, and multidisciplinary collaboration, clinicians can unravel the enigma of abdominal pain and provide optimal patient care.
1.
Discovery reveals protein involved in Parkinson's disease also drives skin cancer
2.
The prognosis of the Slovakian PM; Kate Middleton's treatment; and drug test cheating.
3.
We Don't Always Know What's 'Best' for Our Patients
4.
New tumor therapy approach reduces costs and side effects while increasing accessibility
5.
Dual-action mRNA vaccine takes aim at aggressive skin cancer
1.
The Evolving Arsenal: A 2025 Review of Antibody-Drug Conjugates and the Future of Precision Oncology
2.
Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma
3.
Anion Gap: The Simple Calculation That Reveals Much About Your Health
4.
Contemporary Methods in Hematology Across Clinical Settings
5.
Unlocking the Potential of Cytarabine: A New Era of Cancer Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option
5.
Current Scenario of Cancer- Palliative Care to Close the Care Gap
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation